2021 research period for North America is officially open
March 24, 2021
Research team is now accepting firm submissions, due June 1
US
General Patent Litigation
| General Patent Litigation — Recommended |
|---|
| Arnold & Porter |
| Cooley |
| Covington & Burling |
| Durie Tangri |
| Gibson Dunn & Crutcher |
| Knobbe Martens |
| Mayer Brown |
| McAndrews Held & Malloy |
| Morgan Lewis & Bockius |
| Sterne Kessler Goldstein & Fox |
| Venable |
| Weil Gotshal & Manges |
Hatch-Waxman Patent Litigation (Branded)
| Hatch-Waxman Patent Litigation (Branded) — Highly Recommended |
|---|
| Covington & Burling |
| Finnegan Henderson Farabow Garrett & Dunner |
| Fish & Richardson |
| Paul Hastings |
| Sidley Austin |
| Venable |
| Williams & Connolly |
| WilmerHale |
| Hatch-Waxman Patent Litigation (Branded) — Recommended |
|---|
| Arnold & Porter |
| Bartlit Beck |
| Dechert |
| Jones Day |
| Kirkland & Ellis |
| Latham & Watkins |
| Mayer Brown |
| O'Melveny & Myers |
| Quinn Emanuel Urquhart & Sullivan |
Patent Prosecution
Patent Strategy & Management
| Patent Strategy & Management — Recommended |
|---|
| Arnold & Porter |
| Dechert |
| Fenwick & West |
| Foley & Lardner |
| Greenberg Traurig |
| Hamilton Brook Smith & Reynolds |
| Leydig Voit & Mayer |
| McDonnell Boehnen Hulbert & Berghoff |
| Morgan Lewis & Bockius |
| Venable |
| WilmerHale |
| Lawyer | Section | Practice Area | Location |
|---|---|---|---|
| Adkisson, John | Intellectual Property | General Patent Litigation | Minneapolis |
| Attwell, Gwilym J O | Intellectual Property | Patent Prosecution, Patent Strategy & Management, General Patent Litigation, Hatch-Waxman Patent Litigation | Wilmington |
| Brooks, Juanita | Intellectual Property | General Patent Litigation, Hatch-Waxman Patent Litigation | San Diego |
| Flanagan, Elizabeth | Intellectual Property | General Patent Litigation | Minneapolis |
| Fraser, Janis K | Intellectual Property | Patent Prosecution, Patent Strategy & Management | Boston |
| Garcia, Todd | Intellectual Property | Patent Prosecution, Patent Strategy & Management | Boston |
| Lavoie, Teresa A | Intellectual Property | Patent Prosecution, Patent Strategy & Management | Minneapolis |
| Mahn, Terry | Regulatory | FDA: Pharmaceutical, FDA: Medical Device | Washington, D.C. |
| McCann, Doug | Intellectual Property | General Patent Litigation, Hatch-Waxman Patent Litigation | Wilmington |
| Scherkenbach, Frank | Intellectual Property | General Patent Litigation | Boston |
| Shear, W Chad | Intellectual Property | Patent Strategy & Management, General Patent Litigation, Hatch-Waxman Patent Litigation | San Diego |
| Singer, Jonathan E | Intellectual Property | Patent Strategy & Management, Hatch-Waxman Patent Litigation | San Diego |
| Tyreus Hufnal, Martina | Intellectual Property | Patent Strategy & Management, General Patent Litigation, Hatch-Waxman Patent Litigation | Wilmington |
| Whelan, Dorothy | Intellectual Property | Patent Prosecution, Patent Strategy & Management, General Patent Litigation, Hatch-Waxman Patent Litigation | Minneapolis |
| , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} |
Intellectual Property
Fish & Richardson
Fish & Richardson is highly ranked across practice areas in life sciences IP, including general patent litigation, Hatch-Waxman, patent prosecution and strategy. The firm received significant awards attention from LMG Life Sciences in 2020, earning the title of IP Boutique Firm of the Year and was winner of a Patent Impact Case honor for its involvement in the noteworthy Idenix v Gilead appeal.
Juanita Brooks earns national acclaim for her practice focused on patent litigation, and is turned to by many of the firm's major clients for high-stakes disputes. Among her many recent representations, Brooks was active for GlaxoSmithKline in a pharmaceutical dispute against Teva appealing an adverse decision that removed a $235 million verdict for the client. Chad Shear and Jonathan Singer acted for Gilead in the award-winning appeal against Idenix, which resulted in a novel ruling related to enablement. Following the noteworthy decision from the Federal Circuit, the panel denied the opponent’s request for en banc review. The PTAB arena continues to be a strong suit of the firm under the leadership of Dorothy Whelan, who co-chairs the post-grant proceedings group. Whelan was recently active for a major pharmaceutical client in connection with IPR challenges.
In the non-contentious arena, Teresa Lavoie is one of the firm's practitioners focused on patent strategy and portfolio development, most notably for clients in the biotechnology space. Janis Fraser is another leading patent attorney with a focus on the life sciences sector. She has deep experience as a counselor to biotechnology and pharmaceutical companies, and is noted for her work related to biologics. Gwilym Attwell is well-versed in patent prosecution, strategy and post-grant proceedings. He is currently part of a Fish team representing Astellas and Gilead in connection with a Hatch-Waxman dispute.